This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 ETFs With Big Gains From Nasdaq's Outperformance Last Week
by Sweta Killa
The rounds of strong earnings from some of the biggest tech names have led to the robust rebound.
After a Downbeat 2021, Will Marijuana ETFs Rebound in 2022?
by Sanghamitra Saha
Cannabis stocks and ETFs were massively downbeat in 2021. However, strong sales backdrop, growing medical usage and still-alive chances of a federal approval may cause a bounce back in pot ETFs in 2022.
Cannabis ETFs Soar on Republican-Led Legalization Bill
by Sweta Killa
Cannabis ETFs have gained momentum lately following the reports of a Republican-led bill, which is seeking to legalize marijuana at the federal level in the United States.
Marijuana Secures Top-Performing ETF Spot Last Week
by Sanghamitra Saha
Wall Street was downbeat last week as a strong rally in the main indexes paused due to a high inflation.
September Turns Sour: Top ETF Areas of Last Week
by Sanghamitra Saha
Wall Street ended on a negative note last week just the week before that, strengthening the worth of the adage that September is historically the worst month of the year for stocks.
7 ETFs Up At Least 5% Last Week
by Sanghamitra Saha
Wall Street was muted last week with the S&P 500 gaining but the Dow Jones, the Nasdaq Composite and the Russell 2000 showing a downtrend.
Cannabis ETFs to Surge on Banking Bill Approval in House
by Sanghamitra Saha
On Apr 19, the U.S. House of Representatives okayed legislation that would allow banks to provide services to cannabis companies in states where it is legal.
Cannabis On a Roll: Guide to ETF Investing
by Sanghamitra Saha
Shares of cannabis-related stocks and ETFs continue to be in good shape after a solid run last year.
Cannabis ETF (MSOS) On a High, Reaches $1B AUM Milestone
by Sweta Killa
AdvisorShares Pure US Cannabis ETF (MSOS) has been surging in popularity with its assets growing more than 40,000% in just six months.
5 Best ETF Investing Ideas for 2021
by Sweta Killa
We have highlighted some investing ideas that could prove to be extremely beneficial for investors in 2021.
Top ETF Stories of 2020 & Picks for 2021
by Neena Mishra
We discuss the 2020 trends and outlook for 2021...
ETFs to Buy as Tilray-Aphria Merger Creates Cannabis Giant
by Sweta Killa
Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.
Cannabis ETFs Set to Soar in 2021 on More U.S. Legalization
by Sweta Killa
Given the prospect of loosening regulations and increased legalization, cannabis stocks are set to soar in 2021.
Top Sector ETFs of Record-Setting Last Week
by Sanghamitra Saha
The S&P 500, the Dow Jones and the Nasdaq Composite -- all three indexes touched all-time closing highs to end last week.
ETFs to Bet on Biden's Potential Presidential Victory
by Sweta Killa
Though the election results are yet to become official, many sectors are expected to benefit on Biden's potential victory.
Why Cannabis Stocks & ETFs Are Soaring
by Neena Mishra
Marijuana stocks are rising on hopes of favorable regulatory environment
Cannabis ETFs Hot Ahead of Elections: Here's Why?
by Sweta Killa
With the election just a day away, five states are seeking to legalize marijuana through ballot measures.
5 Sector ETFs That Showed Strength Despite the Worst October
by Sweta Killa
Wall Street registered its first back-to-back monthly loss of this year, with Dow Jones closing out the worst month since March.